APOL1 and chronic kidney disease: AAs have a high frequency (36%) of apolipoprotein L1 (APOL1) gene variants, G1 and G2 [23], that are known to be associated with an increased risk of CKD, but the decline in kidney function associated with APOL1 risk variants has been shown to be dependent on plasma suPAR levels [21].